JP Morgan On CL Outlook

JP Morgan has issued a report on the outlook for Colgate-Palmolive CL following the reported Q1 EPS. JP Morgan writes, "As expected, CL's Q1 results were soft, as organic sales growth missed expectations slightly, while EPS was in-line at $1.16... While we also expect sales to accelerate, for us to get more constructive on the name we would like Colgate to step up their investment levels to protect the LT health of the business, which has deteriorated over the past few years." CL has a Neutral Rating and an $88 Price Target. CL closed at $82.97 a share yesterday.